Dashboard
Manage Tickers

PHRPhreesia, Inc.

NYSE phreesia.com


$ 21.50 $ 0.16 (0.75 %)    

Thursday, 02-May-2024 11:08:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 424.61 $ -0.65 (-0.15 %)
DIA $ 381.18 $ -0.26 (-0.07 %)
SPY $ 503.08 $ -1.32 (-0.26 %)
TLT $ 88.44 $ 0.22 (0.25 %)
GLD $ 213.42 $ 0.96 (0.45 %)
$ 21.01
$ 21.34
$ 21.45 x 100
$ 0.00 x 0
$ 21.14 - $ 21.50
$ 12.05 - $ 34.98
393,255
na
1.15B
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 01-31-2024 10-K
2 12-06-2023 10-31-2023 10-Q
3 09-07-2023 07-31-2023 10-Q
4 06-01-2023 04-30-2023 10-Q
5 03-23-2023 01-31-2023 10-K
6 12-09-2022 10-31-2022 10-Q
7 09-08-2022 07-31-2022 10-Q
8 06-03-2022 04-30-2022 10-Q
9 03-31-2022 01-31-2022 10-K
10 12-09-2021 10-31-2021 10-Q
11 09-02-2021 07-31-2021 10-Q
12 06-04-2021 04-30-2021 10-Q
13 03-31-2021 01-31-2021 10-K
14 12-09-2020 10-31-2020 10-Q
15 09-09-2020 07-31-2020 10-Q
16 06-09-2020 04-30-2020 10-Q
17 04-23-2020 01-31-2020 10-K
18 12-10-2019 10-31-2019 10-Q
19 09-10-2019 07-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stephens--co-reiterates-overweight-on-phreesia-maintains-28-price-target
Stephens & Co. Reiterates Overweight on Ph...
03/22/2024 16:55:39

Stephens & Co. analyst Jeff Garro reiterates Phreesia (NYSE:PHR) with a Overweight and maintains $28 price target.

rbc-capital-reiterates-sector-perform-on-phreesia-maintains-23-price-target
RBC Capital Reiterates Sector Perform on P...
03/21/2024 15:14:32

RBC Capital analyst Sean Dodge reiterates Phreesia (NYSE:PHR) with a Sector Perform and maintains $23 price target.

jmp-securities-maintains-market-outperform-on-phreesia-raises-price-target-to-30
JMP Securities Maintains Market Outperform...
03/21/2024 14:18:03

JMP Securities analyst Joe Goodwin maintains Phreesia (NYSE:PHR) with a Market Outperform and raises the price target from $...

baird-maintains-outperform-on-phreesia-raises-price-target-to-31
Baird Maintains Outperform on Phreesia, Ra...
03/18/2024 11:54:02

Baird analyst Joseph Vruwink maintains Phreesia (NYSE:PHR) with a Outperform and raises the price target from $30 to $31.

needham-reiterates-buy-on-phreesia-maintains-29-price-target
Needham Reiterates Buy on Phreesia, Mainta...
03/15/2024 17:01:23

Needham analyst Ryan MacDonald reiterates Phreesia (NYSE:PHR) with a Buy and maintains $29 price target.

rbc-capital-maintains-sector-perform-on-phreesia-raises-price-target-to-23
RBC Capital Maintains Sector Perform on Ph...
03/15/2024 16:31:12

RBC Capital analyst Sean Dodge maintains Phreesia (NYSE:PHR) with a Sector Perform and raises the price target from $17 to $23.

raymond-james-reiterates-outperform-on-phreesia-raises-price-target-to-30
Raymond James Reiterates Outperform on Phr...
03/15/2024 16:15:06

Raymond James analyst John Ransom reiterates Phreesia (NYSE:PHR) with a Outperform and raises the price target from $25 to $30.

jmp-securities-reiterates-market-outperform-on-phreesia-maintains-28-price-target
JMP Securities Reiterates Market Outperfor...
03/15/2024 14:40:20

JMP Securities analyst Joe Goodwin reiterates Phreesia (NYSE:PHR) with a Market Outperform and maintains $28 price target.

analyst-expectations-for-phreesias-future
Analyst Expectations For Phreesia's Future
03/15/2024 14:01:10

da-davidson-maintains-neutral-on-phreesia-maintains-32-price-target
DA Davidson Maintains Neutral on Phreesia,...
03/15/2024 13:35:08

DA Davidson analyst Robert Simmons maintains Phreesia (NYSE:PHR) with a Neutral and maintains $32 price target.

canaccord-genuity-maintains-buy-on-phreesia-raises-price-target-to-37
Canaccord Genuity Maintains Buy on Phreesi...
03/15/2024 12:22:09

Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $36 to $37.

phreesia-maintains-2025-revenue-outlook-424m-434m-vs-42812m-est-updates-adj-ebitda-outlook-from-10m-20m-to-12m-20m
Phreesia Maintains 2025 Revenue Outlook $4...
03/14/2024 20:48:50

recap-phreesia-q4-earnings
Recap: Phreesia Q4 Earnings
03/14/2024 20:25:31

phreesia-q4-2024-gaap-eps-056-inline-sales-95005m-beat-93535m-estimate
Phreesia Q4 2024 GAAP EPS $(0.56), Inline,...
03/14/2024 20:21:06

Phreesia (NYSE:PHR) reported quarterly losses of $(0.56) per share which met the analyst consensus estimate. The company repor...

earnings-scheduled-for-march-14-2024
Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

phreesia-earnings-preview
Phreesia Earnings Preview
03/13/2024 15:01:07

jmp-securities-reiterates-market-outperform-on-phreesia-maintains-28-price-target
JMP Securities Reiterates Market Outperfor...
03/12/2024 14:12:15

JMP Securities analyst Joe Goodwin reiterates Phreesia (NYSE:PHR) with a Market Outperform and maintains $28 price target.

assessing-phreesia-insights-from-7-financial-analysts
Assessing Phreesia: Insights From 7 Financ...
02/26/2024 18:01:15

truist-securities-initiates-coverage-on-phreesia-with-buy-rating-announces-price-target-of-35
Truist Securities Initiates Coverage On Ph...
02/26/2024 13:12:03

Truist Securities analyst Jailendra Singh initiates coverage on Phreesia (NYSE:PHR) with a Buy rating and announces Price Ta...

phreesia-says-new-data-shows-engaging-patients-with-relevant-cancer-prevention-information-during-check-in-increases-screening-rates
Phreesia Says New Data Shows Engaging Pati...
02/20/2024 11:59:55

One health system asked more than 87,000 patients about mammogram screenings, and 32% of them requested a mammogram appointment.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION